Gold Nanostars Target Drug Directly to the Cancer Cell Nucleus

Nanotechnology, which offers powerful new possibilities for targeted cancer therapies, has been generating a lot of excitement in the cancer research community. Northwestern University scientists recently developed specialized nanoparticle that can deliver a drug directly to a cancer cell’s nucleus — an important feature for effective treatment [1].

Gold nanostars

President Obama Resists Cuts to Biomedical Research Funding

In President Barack Obama’s State of the Union address last month, he argued that government support for research and development to fund innovation is a necessary and critical investment that must be made, even in the face of a rising national debt. A coalition of biomedical researchers support his vision on science. The 2012 budget President Obama sent to Congress earlier this month seeks an increase in funding for biomedical research at the National Institutes of Health (NIH) and in basic science at other agencies, while making cuts and freezes in many other areas of government.

Obama and biomedical research funding

Cancer Research Blog Carnival #13 – Stand Up To Cancer

Welcome to the 13th edition of the Cancer Research Blog Carnival, the blog carnival devoted to cancer research.

There’s a revolution occurring on the Web: those “authoritative” articles written on traditional, static websites are being replaced with blogs, wikis and online social networks. In the sphere of health, medicine and information technology, this “real-time Web” consists of many who are professionals in the field; their posts are listed below.
In the digital age, these are the characteristics of new media: recent, relevant, reachable and reliable.

Everyone knows that cancer is a devastating disease. What many people don’t know is that cancer kills more than 1,500 people a day; that’s one person every minute. Tonight, Stand Up To Cancer, a one-hour fundraising event, will be simulcast on all three major U.S. networks. The goal of Stand Up To Cancer (SU2C) is to enable cutting-edge research aimed at finding a cure to all types of cancer and making cancer part of the national debate.

Since 2001, federal deficits resulting from a number of fiscal pressures, including the wars in Afghanistan and Iraq, increased national defense spending and hurricane Katrina, have together placed significant stress on the resources available for U.S. biomedical research. Between the fiscal years 2004 and 2007, the National Cancer Institute’s budget remained relatively flat. However, factoring in inflation (i.e. a Biomedical Research and Development Price Index (BRDPI) of ~3.8% per year) reveals a 12% loss of purchasing power [1].

This decrease in resources comes as patient demand is growing. There was an estimated 1.5 million new cancer cases in 2007, an increase of 14% since 2001 [2]. The U.S. spends roughly $12 billion dollars every month fighting the wars in Afghanistan and Iraq. That’s 33 times more than what is spent on cancer research annually. Imagine what we could do if just a fraction of those resources was dedicated to cancer research.